Details
Stereochemistry | ACHIRAL |
Molecular Formula | C22H27N9O4 |
Molecular Weight | 481.5077 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C=C(NC=O)C=C1C(=O)NC2=CN(C)C(=C2)C(=O)NC3=CN(C)C(=C3)C(=O)NCCC(N)=N
InChI
InChIKey=UPBAOYRENQEPJO-UHFFFAOYSA-N
InChI=1S/C22H27N9O4/c1-29-9-13(26-12-32)6-17(29)21(34)28-15-8-18(31(3)11-15)22(35)27-14-7-16(30(2)10-14)20(33)25-5-4-19(23)24/h6-12H,4-5H2,1-3H3,(H3,23,24)(H,25,33)(H,26,32)(H,27,35)(H,28,34)
Stallimycin also known as distamycin A is an antibacterial and antitumor compound. It is able to bind to the minor groove of double-stranded B-DNA in a non intercalative manner, where it forms strong reversible complex preferentially at the nucleotide sequences consisting of 4-5 adjacent AT base pairs. The pyrrole-amide skeleton of distamycin A has been also used as DNA sequence selective vehicles for the delivery of alkylating functions to DNA targets, leading to a sharp increase of its cytotoxicity, in comparison to that, very weak, of distamycin itself.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Congocidine and distamycin A, antipoxvirus antibiotics. | 1972 Jun |
|
Structure--activity relationships of pyrrole amidine antiviral antibiotics. 1. Modifications of the alkylamidine side chain. | 1979 Nov |
|
Structure-activity relationship of novel oligopeptide antiviral and antitumor agents related to netropsin and distamycin. | 1986 Jul |
|
Inhibitors of human immunodeficiency virus integrase. | 1993 Mar 15 |
|
Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production. | 1993 Sep 24 |
|
Linked lexitropsins and the in vitro inhibition of HIV-1 reverse transcriptase RNA-directed DNA polymerization: a novel induced-fit of 3,5 m-pyridyl bisdistamycin to enzyme-associated template-primer. | 1996 Dec 3 |
|
Highly potent synthetic polyamides, bisdistamycins, and lexitropsins as inhibitors of human immunodeficiency virus type 1 integrase. | 1998 Aug |
|
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1, 4]benzodiazepine and minor-groove-binding oligopyrrole carriers. | 1999 Dec 16 |
|
Inhibition of HIV-1 integrase-catalysed reaction by new DNA minor groove ligands: the oligo-1,3-thiazolecarboxamide derivatives. | 2000 Nov |
|
Antiviral activity of distamycin A against vaccinia virus is the result of inhibition of postreplicative mRNA synthesis. | 2004 Feb |
|
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA. | 2004 Feb 1 |
|
Distamycin A and derivatives as synergic drugs in cisplatin-sensitive and -resistant ovarian cancer cells. | 2012 Feb |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C2115
Created by
admin on Sat Dec 16 15:46:50 GMT 2023 , Edited by admin on Sat Dec 16 15:46:50 GMT 2023
|
||
|
NCI_THESAURUS |
C446
Created by
admin on Sat Dec 16 15:46:50 GMT 2023 , Edited by admin on Sat Dec 16 15:46:50 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000083833
Created by
admin on Sat Dec 16 15:46:50 GMT 2023 , Edited by admin on Sat Dec 16 15:46:50 GMT 2023
|
PRIMARY | |||
|
80O63P88IS
Created by
admin on Sat Dec 16 15:46:50 GMT 2023 , Edited by admin on Sat Dec 16 15:46:50 GMT 2023
|
PRIMARY | |||
|
636-47-5
Created by
admin on Sat Dec 16 15:46:50 GMT 2023 , Edited by admin on Sat Dec 16 15:46:50 GMT 2023
|
PRIMARY | |||
|
82150
Created by
admin on Sat Dec 16 15:46:50 GMT 2023 , Edited by admin on Sat Dec 16 15:46:50 GMT 2023
|
PRIMARY | |||
|
DTXSID9045637
Created by
admin on Sat Dec 16 15:46:50 GMT 2023 , Edited by admin on Sat Dec 16 15:46:50 GMT 2023
|
PRIMARY | |||
|
SUB10640MIG
Created by
admin on Sat Dec 16 15:46:50 GMT 2023 , Edited by admin on Sat Dec 16 15:46:50 GMT 2023
|
PRIMARY | |||
|
C1517
Created by
admin on Sat Dec 16 15:46:50 GMT 2023 , Edited by admin on Sat Dec 16 15:46:50 GMT 2023
|
PRIMARY | |||
|
3346
Created by
admin on Sat Dec 16 15:46:50 GMT 2023 , Edited by admin on Sat Dec 16 15:46:50 GMT 2023
|
PRIMARY | |||
|
3553
Created by
admin on Sat Dec 16 15:46:50 GMT 2023 , Edited by admin on Sat Dec 16 15:46:50 GMT 2023
|
PRIMARY | |||
|
CHEMBL11252
Created by
admin on Sat Dec 16 15:46:50 GMT 2023 , Edited by admin on Sat Dec 16 15:46:50 GMT 2023
|
PRIMARY | |||
|
m4674
Created by
admin on Sat Dec 16 15:46:50 GMT 2023 , Edited by admin on Sat Dec 16 15:46:50 GMT 2023
|
PRIMARY | Merck Index | ||
|
C030000
Created by
admin on Sat Dec 16 15:46:50 GMT 2023 , Edited by admin on Sat Dec 16 15:46:50 GMT 2023
|
PRIMARY | |||
|
3115
Created by
admin on Sat Dec 16 15:46:50 GMT 2023 , Edited by admin on Sat Dec 16 15:46:50 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)